A product of constitutive tryptophan catabolism via tryptophan-2,3-dioxygenase in the liver and human gliomas that is associated with the suppression of antitumor immune responses; activates the AhR target gene CYP1A1 (EC50 = 12.3 μM) and binds to AhR (Kd ~4 μM).